Delivery Order SPE2DB22D1106-SPE2DB25FFHZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lamotrigine ODT 200 mg tablets in quantities of 30 units, valued at $1,269.11. This firm fixed-price delivery order, set to be completed by August 8, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was competitively awarded without set-aside provisions, reflecting the vendor's demonstrated capability...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,444.38 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ODT (orally disintegrating tablets) 50 mg in quantities of 30 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting the open competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ER 25 mg tablets in 30-count units, with a ceiling value of $1,264.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lamotrigine ER 300 mg tablets in a quantity of 30 units, valued at $2,357.64. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ER 300 mg tablets (30-count units) with a ceiling value of $1,331.43. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 11, 2025, with performance to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a $3,943.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lamotrigine ER 300 mg tablets in quantities of 30 units. This contract is valued at $1,704.06 with a firm fixed price structure and a completion date of August 26, 2025. The order represents a non-competitive, non-set-aside delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHZ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ODT 100 mg tablets (30-unit quantity) under a firm fixed-price contract valued at $11,986.07. This non-set-aside competitive award represents a single delivery order for this generic neurological medication, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor agreement enables the contractor to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. AmerisourceBergen's continued selection for such critical medical supply contracts demonstrates its capability to meet federal procurement standards through competitive procurement processes across diverse pharmaceutical therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/10/25 |